Both in Pharmaceuticals
Phibro Animal Health vs Supernus
Over the past year PAHC returned −6.4% and SUPN returned −50.5%; their daily moves had a correlation of 0.16.
PAHC −6.4% SUPN −50.5%Growth of $1, one year, split-adjusted
| Metric | PAHC | SUPN |
|---|---|---|
| Price | $39.43 | $28.21 |
| Market cap | $1.60B | $1.64B |
| Today | +4.73% | +0.21% |
| 1 month | +7.7% | −34.1% |
| 6 months | −32.6% | −45.2% |
| Year to date | +5.5% | −43.2% |
| 1 year | −9.1% | — |
| Revenue growth (YoY) | +4.8% | +18.0% |
| Gross margin | 33.9% | 88.1% |
| Net margin | 5.5% | 9.2% |
| P/E (TTM) | 16.1× | — |
| Price / sales | 1.1× | 1.9× |
| Net cash | -$650.8M | $359.5M |
| Dividend yield | 1.22% | 28.82% |
| Volatility (60d) | 31.5% | 86.1% |
| Short % of float | 4.9% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).